Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab synovial tissue response study in rheumatoid arthritis
NL-OMON19978Active, not recruiting
- Sponsor
- Academic Medical Center
- Start
- Mar 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of rituximab in rheumatoid arthritis (RA), sponsored by Academic Medical Center. Primary endpoint: Synovial tissue response and predictors of clinical response. Started Mar 2005; status: active, not recruiting.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON19978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON19978.